Search

Your search keyword '"Mells, G"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Mells, G" Remove constraint Author: "Mells, G" Topic liver cirrhosis, biliary Remove constraint Topic: liver cirrhosis, biliary
31 results on '"Mells, G"'

Search Results

1. Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

2. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.

Catalog

Books, media, physical & digital resources

3. Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis.

4. Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

5. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.

6. The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.

7. The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

8. Understanding Fatigue in Primary Biliary Cholangitis.

10. PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis.

11. Prognostic models in primary biliary cholangitis.

12. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.

13. Individualizing Care: Management Beyond Medical Therapy.

15. The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.

16. A validated clinical tool for the prediction of varices in PBC: the Newcastle Varices in PBC Score.

17. Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation.

18. The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis

19. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis

20. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

21. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

22. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

23. Effects of primary biliary cholangitis on quality of life and health care costs in the United Kingdom

24. Prognostic models in primary biliary cholangitis

25. Individualizing Care: Management Beyond Medical Therapy

26. Letter: histology is relevant for risk stratification in primary biliary cholangitis

27. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

28. Toward precision medicine in primary biliary cholangitis

29. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid

30. The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort

31. Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation